These observations collectively suggest that EBV-miR-BART6-5p exerts its regulatory effects on the phenotype and glycolysis of gastric cancer cells through modulation of the TGF-β/SMAD4 pathway. The gene discussed is SMAD4; the disease is gastric cancer.